COPD Exacerbations: BET With Prednisolone Noninferior to ST

Results of a randomized trial suggest that blood eosinophil-directed prednisolone can be an option to reduce glucocorticoid use in COPD patients.

Related Keywords

United Kingdom ,Sanjay Ramakrishnan ,University Of Oxford ,Lancet Respiratory Medicine ,Chronic Obstructive Pulmonary Disease ,Opd Chronic Obstructive Pulmonary Disease ,Copd ,Chronic Obstructive Lung Disease ,Oad Chronic Obstructive Airway Disease Coad ,Eosinophils ,Osinophil Granulocytes ,Blood ,Quality Of Life ,Pol ,Ealth Related Quality Of Life ,Rqol ,Glucocorticosteroids ,Glucocorticoid Therapy ,Glucocorticoid ,Practice Management ,Revenue ,